快速检索
年期检索
摘要： Objective To study the policies of integrating medical resources and centralized drug procurement in China from 2018 to 2020, and to provide a reference for large pharmaceutical commercial companies to select partners. Methods Analytic hierarchy process (AHP) and fuzzy synthesis evaluation method were used to establish the index evaluation system and assign values to each index. Results and Conclusion According to the questionnaire survey data, the weight of each evaluation index was determined, and the evaluation results were obtained by using the fuzzy synthesis evaluation method. The selection of production enterprises by large pharmaceutical commercial companies includes five first-level indicators and 11 second-level indicators. They can provide a favorable reference for the selection of production enterprises by large pharmaceutical commercial companies against the background of complex pharmaceutical industry.
